• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南澳大利亚硬皮病研究:患病率、亚型特征及甲襞毛细血管镜检查

A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy.

作者信息

Chandran G, Smith M, Ahern M J, Roberts-Thomson P J

机构信息

Rheumatology Unit, Flinders Medical Centre, Adelaide, SA.

出版信息

Aust N Z J Med. 1995 Dec;25(6):688-94. doi: 10.1111/j.1445-5994.1995.tb02854.x.

DOI:10.1111/j.1445-5994.1995.tb02854.x
PMID:8770332
Abstract

BACKGROUND

Scleroderma is a systemic rheumatic disorder seen in a wide range of clinical specialties.

AIMS

To establish the prevalence and mortality rates of scleroderma in South Australia (SA), to determine the relative frequency and characteristics of the three principal subsets (diffuse, limited and overlap), and to examine the role of nailfold capillaroscopy in subset identification and implied prognosis.

METHODS

Outpatient and discharge diagnostic indexes from five major teaching hospitals in SA were reviewed between February 1987 and November 1993. A total of 215 patients with scleroderma were identified. Case notes of 115 of these patients were reviewed in order to validate scleroderma diagnosis, and subset characteristics such as sex, mean age at diagnosis, extent of skin involvement, internal organ involvement and serology were analysed. Fifty-two of these patients were then examined prospectively to confirm positive discharge diagnosis, and nailfold capillaroscopy was performed on these patients.

RESULTS

The point prevalence of scleroderma in SA for 1993 was estimated to be 208/10 This figure is a conservative estimate and is higher than most other reported series. The female to male ratio was 4:1. The majority of patients had limited disease with a ratio of 6:1:1.6 limited vs diffuse vs overlap. Systemic involvement excluding the oesophageal components limited disease was found predominantly in the diffuse group. Autoimmune serology was positive in 90% of patients, with Scl-70 being more common in diffuse scleroderma, anti-centromere antibody (ACA) in the limited form and anti-ribonucleoprotein (RNP) in the overlap form. Nailfold capillaroscopy was useful in predicting disease-subtype as capillary dilatation was observed predominantly in limited disease, capillary dropout in diffuse disease.

CONCLUSIONS

Scleroderma is more common in SA than previously recognised. Limited disease is more common than diffuse or overlap disease, carries a better prognosis and in associated with ACA. Nailfold capillaroscopy is a useful tool in disease assessment and may provide useful diagnostic and prognostic information.

摘要

背景

硬皮病是一种在广泛临床专科中可见的系统性风湿性疾病。

目的

确定南澳大利亚州(SA)硬皮病的患病率和死亡率,确定三个主要亚型(弥漫型、局限型和重叠型)的相对频率及特征,并研究甲襞毛细血管镜检查在亚型识别及隐含预后方面的作用。

方法

回顾了1987年2月至1993年11月期间SA五家主要教学医院的门诊及出院诊断指标。共识别出215例硬皮病患者。对其中115例患者的病历进行回顾以验证硬皮病诊断,并分析亚型特征,如性别、诊断时的平均年龄、皮肤受累范围、内脏器官受累情况及血清学。然后对其中52例患者进行前瞻性检查以确认出院诊断,并对这些患者进行甲襞毛细血管镜检查。

结果

1993年SA硬皮病的点患病率估计为208/10万。该数字为保守估计,高于大多数其他报道系列。男女比例为4:1。大多数患者为局限型疾病,局限型、弥漫型和重叠型的比例为6:1:1.6。排除食管成分的系统性受累在局限型疾病中主要见于弥漫型组。90%的患者自身免疫血清学呈阳性,Scl - 70在弥漫性硬皮病中更常见,抗着丝点抗体(ACA)在局限型中常见,抗核糖核蛋白(RNP)在重叠型中常见。甲襞毛细血管镜检查有助于预测疾病亚型,因为毛细血管扩张主要见于局限型疾病,毛细血管缺失见于弥漫型疾病。

结论

硬皮病在SA比之前认为的更常见。局限型疾病比弥漫型或重叠型疾病更常见,预后更好且与ACA相关。甲襞毛细血管镜检查是疾病评估的有用工具,可能提供有用的诊断和预后信息。

相似文献

1
A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy.南澳大利亚硬皮病研究:患病率、亚型特征及甲襞毛细血管镜检查
Aust N Z J Med. 1995 Dec;25(6):688-94. doi: 10.1111/j.1445-5994.1995.tb02854.x.
2
The role of nailfold capillary dropout on mortality in systemic sclerosis.甲襞毛细血管缺失在系统性硬化症死亡率中的作用。
Intern Med J. 2018 May;48(5):517-523. doi: 10.1111/imj.13745.
3
Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity.硬皮病患者甲襞微血管镜检查模式与疾病亚型及疾病严重程度相关。
Rheumatology (Oxford). 2007 Oct;46(10):1566-9. doi: 10.1093/rheumatology/kem190. Epub 2007 Aug 10.
4
Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension.局限性硬皮病合并肺动脉高压时甲襞毛细血管密度降低。
Asian Pac J Allergy Immunol. 1998 Jun-Sep;16(2-3):81-6.
5
Inflammatory myopathies in childhood: correlation between nailfold capillaroscopy findings and clinical and laboratory data.儿童炎性肌病:甲襞毛细血管镜检查结果与临床及实验室数据的相关性
J Pediatr (Rio J). 2006 Jan-Feb;82(1):40-5. doi: 10.2223/JPED.1435.
6
Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.系统性硬化症的指端溃疡和皮肤亚组:西班牙RESCLE注册研究中的临床、免疫学、甲襞毛细血管镜检查及生存差异
Semin Arthritis Rheum. 2016 Oct;46(2):200-208. doi: 10.1016/j.semarthrit.2016.04.007. Epub 2016 May 18.
7
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.系统性硬化症患者甲襞视频毛细血管镜检查中硬皮病模式的患病率及演变:临床和预后意义
Microvasc Res. 2015 May;99:92-5. doi: 10.1016/j.mvr.2015.03.005. Epub 2015 Apr 2.
8
Nailfold capillaroscopy: a blinded study of its discriminatory value in scleroderma, systemic lupus erythematosus, and rheumatoid arthritis.
Aust N Z J Med. 1986 Aug;16(4):457-60. doi: 10.1111/j.1445-5994.1986.tb02010.x.
9
Capillary density: An important parameter in nailfold capillaroscopy.毛细血管密度:甲襞毛细血管镜检查中的一个重要参数。
Microvasc Res. 2017 Jan;109:7-18. doi: 10.1016/j.mvr.2016.09.001. Epub 2016 Sep 7.
10
Microvascular abnormalities in Sjögren's syndrome: nailfold capillaroscopy.干燥综合征中的微血管异常:甲襞毛细血管镜检查
Rheumatology (Oxford). 1999 Sep;38(9):826-30. doi: 10.1093/rheumatology/38.9.826.

引用本文的文献

1
Connexin 37, 40, 43 and Pannexin 1 Expression in the Gastric Mucosa of Patients with Systemic Sclerosis.系统性硬化症患者胃黏膜中连接蛋白37、40、43和泛连接蛋白1的表达
Biomedicines. 2023 Sep 7;11(9):2487. doi: 10.3390/biomedicines11092487.
2
Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health.2017-2020 年泰国系统性硬化症的发病率和患病率:来自公共卫生部的数据库。
Clin Rheumatol. 2023 Jul;42(7):1767-1774. doi: 10.1007/s10067-023-06550-7. Epub 2023 Mar 10.
3
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update.
通过甲襞视频毛细血管显微镜评估系统性硬化症中的特异性自身抗体与微血管损伤进展:是否存在特殊关联?最新进展。
Antibodies (Basel). 2023 Jan 4;12(1):3. doi: 10.3390/antib12010003.
4
Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis.全球系统性硬化症的发病率和患病率:一项全面的系统评价和荟萃分析。
Rheumatology (Oxford). 2021 Jul 1;60(7):3121-3133. doi: 10.1093/rheumatology/keab190.
5
Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature.系统性硬化症中甲襞微血管检查评估的性别和自身抗体对微血管病变的影响:系统综述文献。
Arthritis Care Res (Hoboken). 2021 May;73(5):722-731. doi: 10.1002/acr.24149. Epub 2021 Apr 3.
6
Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study.量化系统性硬化症的直接公共医疗保健成本:一项全面的数据关联研究。
Medicine (Baltimore). 2017 Dec;96(48):e8503. doi: 10.1097/MD.0000000000008503.
7
Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.系统性硬化症相关肺动脉高压的流行病学及疾病特征:一项真实世界筛查项目的结果
Arthritis Res Ther. 2017 Mar 7;19(1):42. doi: 10.1186/s13075-017-1250-z.
8
Recent advances in the treatment of systemic sclerosis.系统性硬化症治疗的最新进展
Clin Rev Allergy Immunol. 2009 Jun;36(2-3):176-200. doi: 10.1007/s12016-008-8114-x.
9
[Capillaroscopy and rheumatic diseases: state of the art].[毛细血管镜检查与风湿性疾病:现状]
Z Rheumatol. 2006 Jul;65(4):290-6. doi: 10.1007/s00393-006-0071-2.
10
Systemic sclerosis mortality in the United States: 1979-1998.美国1979 - 1998年系统性硬化症死亡率
Eur J Epidemiol. 2005;20(10):855-61. doi: 10.1007/s10654-005-2210-5.